Skip to main content
Premium Trial:

Request an Annual Quote

Veracyte: William Bulman, Paul Kelly Marcom

Veracyte has appointed William Bulman and Paul Kelly Marcom as its medical director for lung cancer and medical director for breast cancer, respectively.

Bulman most recently served as associate professor of medicine at Columbia University and director of bronchoscopy at New York Presbyterian Hospital. He has also served as course director for the pulmonary medicine section of the first-year curriculum at Columbia University Vagelos College of Physicians and Surgeons, director of the medical school’s Scholarly Projects Program, medical director of the High-Risk Lung Nodule Assessment Center, and the medical director of Columbia Pulmonary Associates.

Marcom previously served as disease group leader at Duke University Medical Institute's breast cancer disease group and as a tenured professor of medicine. He as also served as a member of the National Comprehensive Cancer Network EHR oncology advisory group and breast cancer panel. 

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.